Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Moldoveanu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pneumologia (Bucharest, Romania)|May 10, 2011
[Update regarding the role of biomarkers in early diagnosis of non-small cell bronchopulmonary cancer]Antonela Dragomir, Elena Moldoveanu, Fl Mihălţan
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 10, 2012
Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarkerOana Vittos, Bogdan Toana, Alexandros Vittos, et al.
Haematologia|June 1, 2002
The antiphospholipid antibodiesCristina Tanaseanu, Elena Moldoveanu, St Tanaseanu, et al.
Journal of Cellular and Molecular Medicine|November 5, 2003
Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokinesElena Moldoveanu, Andreea Moicean, Cristina Vidulescu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 28, 2011
Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fractionElena Moldoveanu, Mihnea Serban, Daciana S Marta, et al.
European Journal of Medical Research|May 19, 2007
Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosusC Tanaseanu, S Tudor, I Tamsulea, et al.
European Journal of Internal Medicine|September 29, 2004
The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable anginaCristina Tanaseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
Clinical Chemistry and Laboratory Medicine|July 8, 2008
Antioxidant defense capacity in scleroderma patientsRoxana Sfrent-Cornateanu, Carina Mihai, Irina Stoian, et al.
European Journal of Internal Medicine|December 28, 2005
Plasma markers of endothelial dysfunction in type 2 diabeticsElena Moldoveanu, Cristina Tanaseanu, Stefanita Tanaseanu, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|November 6, 2004
Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results)Cristina Tănăseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pneumologia (Bucharest, Romania)|May 10, 2011
[Update regarding the role of biomarkers in early diagnosis of non-small cell bronchopulmonary cancer]Antonela Dragomir, Elena Moldoveanu, Fl Mihălţan
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 10, 2012
Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarkerOana Vittos, Bogdan Toana, Alexandros Vittos, et al.
Haematologia|June 1, 2002
The antiphospholipid antibodiesCristina Tanaseanu, Elena Moldoveanu, St Tanaseanu, et al.
Journal of Cellular and Molecular Medicine|November 5, 2003
Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokinesElena Moldoveanu, Andreea Moicean, Cristina Vidulescu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 28, 2011
Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fractionElena Moldoveanu, Mihnea Serban, Daciana S Marta, et al.
European Journal of Medical Research|May 19, 2007
Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosusC Tanaseanu, S Tudor, I Tamsulea, et al.
European Journal of Internal Medicine|September 29, 2004
The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable anginaCristina Tanaseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
Clinical Chemistry and Laboratory Medicine|July 8, 2008
Antioxidant defense capacity in scleroderma patientsRoxana Sfrent-Cornateanu, Carina Mihai, Irina Stoian, et al.
European Journal of Internal Medicine|December 28, 2005
Plasma markers of endothelial dysfunction in type 2 diabeticsElena Moldoveanu, Cristina Tanaseanu, Stefanita Tanaseanu, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|November 6, 2004
Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results)Cristina Tănăseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
Pageof 2